Wealth Enhancement Advisory Services LLC Buys 2,264 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Wealth Enhancement Advisory Services LLC raised its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 33.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,061 shares of the medical device company’s stock after purchasing an additional 2,264 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Cooper Companies were worth $1,000,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the stock. Quantbot Technologies LP acquired a new position in Cooper Companies in the 1st quarter valued at $2,211,000. Envestnet Portfolio Solutions Inc. raised its holdings in shares of Cooper Companies by 43.1% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company’s stock worth $3,076,000 after buying an additional 10,616 shares in the last quarter. Axxcess Wealth Management LLC raised its holdings in shares of Cooper Companies by 298.4% during the 1st quarter. Axxcess Wealth Management LLC now owns 8,211 shares of the medical device company’s stock worth $833,000 after buying an additional 6,150 shares in the last quarter. Nordea Investment Management AB raised its holdings in shares of Cooper Companies by 315.1% during the 1st quarter. Nordea Investment Management AB now owns 16,120 shares of the medical device company’s stock worth $1,642,000 after buying an additional 12,237 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado raised its holdings in shares of Cooper Companies by 298.9% during the 1st quarter. Public Employees Retirement Association of Colorado now owns 245,793 shares of the medical device company’s stock worth $24,938,000 after buying an additional 184,171 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on COO shares. Stifel Nicolaus reissued a “buy” rating and set a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Wells Fargo & Company upped their target price on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Morgan Stanley upped their target price on Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a report on Tuesday, September 10th. Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and upped their target price for the stock from $107.00 to $115.00 in a report on Tuesday, July 16th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Insider Activity at Cooper Companies

In related news, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the sale, the chief financial officer now owns 6,614 shares in the company, valued at $700,422.60. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the transaction, the chief financial officer now directly owns 6,614 shares of the company’s stock, valued at approximately $700,422.60. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Daniel G. Mcbride sold 114,992 shares of the stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the sale, the chief operating officer now directly owns 44,696 shares of the company’s stock, valued at approximately $4,714,534.08. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 256,373 shares of company stock worth $27,637,427 in the last 90 days. Corporate insiders own 2.00% of the company’s stock.

Cooper Companies Trading Up 0.3 %

NASDAQ COO opened at $105.21 on Wednesday. The business’s 50-day moving average price is $106.99 and its two-hundred day moving average price is $97.26. The Cooper Companies, Inc. has a 12 month low of $80.48 and a 12 month high of $112.38. The firm has a market capitalization of $20.95 billion, a PE ratio of 58.64, a price-to-earnings-growth ratio of 2.28 and a beta of 0.99. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. During the same quarter in the previous year, the company posted $0.84 EPS. The business’s revenue was up 7.8% on a year-over-year basis. On average, analysts expect that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.